Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Itraconazole-loaded nanoparticles are more effective and less toxic for treating fungal infections than conventional oral itraconazole.

Nanoparticles improve cancer treatment by reducing side effects and targeting cancer cells better.

The treatment significantly improved lymphocytic cicatricial alopecia symptoms in most patients.

A botanical extract was found to be a safe treatment that may prevent hair loss in chemotherapy patients.

Chemotherapy often causes hair loss, nail changes, and mouth issues, but these are usually manageable.

Pembrolizumab can cause unusual eyelash growth, but it may still be worth continuing if cancer treatment is effective.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

Amivantamab treatment often causes skin issues that can affect quality of life and treatment continuation.

Both VEPA and ML-Y1 treatments are not effective enough for elderly non-Hodgkin's lymphoma patients.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Combining Western chemotherapy with Traditional Chinese Medicine can reduce side effects and improve immune response in treating bone and soft tissue tumors.

Certain peptides can prevent hair loss in young rats caused by a cancer drug.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

P-SLN nanoparticles effectively deliver podophyllotoxin to the skin.

Thalidomide with CHOP is more effective for peripheral T-cell lymphoma than CHOP alone.

PCA hydrogel promotes hair growth by enhancing blood vessel formation and hair follicle stem cell activity.

Cannabinoids may help treat chronic and chemotherapy-induced neuropathic pain, but more research is needed to confirm their effectiveness and safety.

The patient showed tumor stability and improved health using a new Periwinkle preparation with chemotherapy.

Topical vasoconstrictors do not reduce chemotherapy effectiveness against leukemia in mice.

Boron neutron capture therapy for head and neck cancer can cause side effects like mouth sores and skin irritation, which vary depending on where the treatment is aimed.

Estradiol and castration reduced prostate cancer development in rats when applied at early stages, but were ineffective after cancer was established.

Targeting androgen receptors shows promise for treating triple-negative breast cancer, but more research is needed.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

PROTACs show promise for cancer treatment, but designing them effectively is challenging.

A PTH-based treatment improved hair regrowth better than ruxolitinib in a mouse model of hair loss.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

Combining pemetrexed with platinum drugs improves treatment outcomes and quality of life for elderly patients with advanced lung adenocarcinoma.

Tofacitinib improved ulcerative colitis, skin ulcers, and hair loss in a patient who didn't respond well to other treatments.